|
1
|
Clarke JD, Dashwood RH and Ho E:
Multi-targeted prevention of cancer by sulforaphane. Cancer Lett.
269:291–304. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brooks JD, Paton VG and Vidanes G: Potent
induction of phase 2 enzymes in human prostate cells by
sulforaphane. Cancer Epidemiol Biomarkers Prev. 10:949–954.
2001.PubMed/NCBI
|
|
3
|
Hecht SS, Kenney PM, Wang M and Upadhyaya
P: Benzyl isothiocyanate: An effective inhibitor of polycyclic
aromatic hydrocarbon tumorigenesis in A/J mouse lung. Cancer Lett.
187:87–94. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Y, Kensler TW, Cho CG, Posner GH and
Talalay P: Anticarcinogenic activities of sulforaphane and
structurally related synthetic norbornyl isothiocyanates. Proc Natl
Acad Sci USA. 91:3147–3150. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singletary K and MacDonald C: Inhibition
of benzo[a]pyrene- and 1,6-dinitropyrene-DNA adduct formation in
human mammary epithelial cells bydibenzoylmethane and sulforaphane.
Cancer Lett. 155:47–54. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fahey JW, Haristoy X, Dolan PM, Kensler
TW, Scholtus I, Stephenson KK, Talalay P and Lozniewski A:
Sulforaphane inhibits extracellular, intracellular, and
antibiotic-resistant strains of Helicobacter pylori and prevents
benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci USA.
99:7610–7615. 2002. View Article : Google Scholar
|
|
7
|
Kassie F, Uhl M, Rabot S, Grasl-Kraupp B,
Verkerk R, Kundi M, Chabicovsky M, Schulte-Hermann R and Knasmüller
S: Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline
(IQ)-induced colonic and hepatic preneoplastic lesions in the F344
rat by cruciferous vegetables administered simultaneously with the
carcinogen. Carcinogenesis. 24:255–261. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chung FL, Conaway CC, Rao CV and Reddy BS:
Chemoprevention of colonic aberrant crypt foci in Fischer rats by
sulforaphane and phenethyl isothiocyanate. Carcinogenesis.
21:2287–2291. 2000. View Article : Google Scholar
|
|
9
|
Verhoeven DT, Verhagen H, Goldbohm RA, van
den Brandt PA and van Poppel G: A review of mechanisms underlying
anti-carcinogenicity by brassica vegetables. Chem Biol Interact.
103:79–129. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Harper JW, Adami GR, Wei N, Keyomarsi K
and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent
inhibitor of G1 cyclin-dependent kinases. Cell. 75:805–816. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiong Y, Hannon GJ, Zhang H, Casso D,
Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin
kinases. Nature. 366:701–704. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Denicourt C and Dowdy SF: Cip/Kip
proteins: More than just CDKs inhibitors. Genes Dev. 18:851–855.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gartel AL, Serfas MS and Tyner AL:
p21-negative regulator of the cell cycle. Proc Soc Exp Biol Med.
213:138–149. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Waldman T, Kinzler KW and Vogelstein B:
p21 is necessary for the p53-mediated G1 arrest in human cancer
cells. Cancer Res. 55:5187–5190. 1995.PubMed/NCBI
|
|
15
|
Wu H, Wade M, Krall L, Grisham J, Xiong Y
and Van Dyke T: Targeted in vivo expression of the cyclin-dependent
kinase inhibitor p21 halts hepatocyte cell-cycle progression,
postnatal liver development and regeneration. Genes Dev.
10:245–260. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bunz F, Dutriaux A, Lengauer C, Waldman T,
Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B:
Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
Science. 282:1497–1501. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sharpless NE and DePinho RA: Telomeres,
stem cells, senescence, and cancer. J Clin Invest. 113:160–168.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cariou S, Donovan JC, Flanagan WM, Milic
A, Bhattacharya N and Slingerland JM: Down-regulation of
p21WAF1/CIP1 or p27Kip1 abrogates
antiestrogen-mediated cell cycle arrest in human breast cancer
cells. Proc Natl Acad Sci USA. 97:9042–9046. 2000. View Article : Google Scholar
|
|
19
|
Giannakakou P, Robey R, Fojo T and
Blagosklonny MV: Low concentrations of paclitaxel induce cell
type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest:
Molecular determinants of paclitaxel-induced cytotoxicity.
Oncogene. 20:3806–3813. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baldin V, Lukas J, Marcote MJ, Pagano M
and Draetta G: Cyclin D1 is a nuclear protein required for cell
cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sellers WR and Kaelin WG Jr: Role of the
retinoblastoma protein in the pathogenesis of human cancer. J Clin
Oncol. 15:3301–3312. 1997.PubMed/NCBI
|
|
22
|
Malumbres M, Sotillo R, Santamaría D,
Galán J, Cerezo A, Ortega S, Dubus P and Barbacid M: Mammalian
cells cycle without the D-type cyclin-dependent kinases Cdk4 and
Cdk6. Cell. 118:493–504. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Donnellan R and Chetty R: Cyclin D1 and
human neoplasia. Mol Pathol. 51:1–7. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Litwiniec A, Gackowska L, Helmin-Basa A,
Zuryń A and Grzanka A: Low-dose etoposide-treatment induces
endoreplication and cell death accompanied by cytoskeletal
alterations in A549 cells: Does the response involve senescence?
The possible role of vimentin. Cancer Cell Int. 13:92013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang H, Hu YD, Li N and Zhu Y: Inhibition
of tumor growth and metastasis by non-small cell lung cancer cells
transfected with cyclin D1-targeted siRNA. Oligonucleotides.
19:151–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(T)(−Delta Delta C) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Pledgie-Tracy A, Sobolewski MD and
Davidson NE: Sulforaphane induces cell type-specific apoptosis in
human breast cancer cell lines. Mol Cancer Ther. 6:1013–1021. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Singh AV, Xiao D, Lew KL, Dhir R and Singh
SV: Sulforaphane induces caspase-mediated apoptosis in cultured
PC-3 human prostate cancer cells and retards growth of PC-3
xenografts in vivo. Carcinogenesis. 25:83–90. 2004. View Article : Google Scholar
|
|
29
|
Herman-Antosiewicz A, Johnson DE and Singh
SV: Sulforaphane causes autophagy to inhibit release of cytochrome
C and apoptosis in human prostate cancer cells. Cancer Res.
66:5828–5835. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mi L, Wang X, Govind S, Hood BL, Veenstra
TD, Conrads TP, Saha DT, Goldman R and Chung FL: The role of
protein binding in induction of apoptosis by phenethyl
isothiocyanate and sulforaphane in human non-small lung cancer
cells. Cancer Res. 67:6409–6416. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jin CY, Moon DO, Lee JD, Heo MS, Choi YH,
Lee CM, Park YM and Kim GY: Sulforaphane sensitizes tumor necrosis
factor-related apoptosis-inducing ligand-mediated apoptosis through
downregulation of ERK and Akt in lung adenocarcinoma A549 cells.
Carcinogenesis. 28:1058–1066. 2007. View Article : Google Scholar
|
|
32
|
Chaudhuri D, Orsulic S and Ashok BT:
Antiproliferative activity of sulforaphane in Akt-overexpressing
ovarian cancer cells. Mol Cancer Ther. 6:334–345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bustany S, Cahu J, Guardiola P and Sola B:
Cyclin D1 sensitizes myeloma cells to endoplasmic reticulum
stress-mediated apoptosis by activating the unfolded protein
response pathway. BMC Cancer. 15:2622015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kuroda Y, Sakai A, Tsuyama N, Katayama Y,
Munemasa S, Asaoku H, Okikawa Y, Nakaju N, Mizuno M, Ogawa K, et
al: Ectopic cyclin D1 overexpression increases chemosensitivity but
not cell proliferation in multiple myeloma. Int J Oncol.
33:1201–1213. 2008.PubMed/NCBI
|
|
35
|
Roué G, Pichereau V, Lincet H, Colomer D
and Sola B: Cyclin D1 mediates resistance to apoptosis through
upregulation of molecular chaperones and consequent redistribution
of cell death regulators. Oncogene. 27:4909–4920. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim JE, Ryu HJ, Kim MJ and Kang TC: LIM
kinase-2 induces programmed necrotic neuronal death via dysfunction
of DRP1-mediated mitochondrial fission. Cell Death Differ.
21:1036–1049. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zuryń A, Litwiniec A,
Klimaszewska-Wiśniewska A, Nowak JM, Gackowska L, Myśliwiec BJ,
Pawlik A and Grzanka A: Expression of cyclin D1 after treatment
with doxorubicin in the HL-60 cell line. Cell Biol Int. 38:857–867.
2014. View Article : Google Scholar
|
|
38
|
Shankar S, Ganapathy S and Srivastava RK:
Sulforaphane enhances the therapeutic potential of TRAIL in
prostate cancer orthotopic model through regulation of apoptosis,
metastasis, and angiogenesis. Clin Cancer Res. 14:6855–6866. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shen G, Xu C, Chen C, Hebbar V and Kong
AN: p53-independent G1 cell cycle arrest of human colon carcinoma
cells HT-29 by sulforaphane is associated with induction of p21CIP1
and inhibition of expression of cyclin D1. Cancer Chemother
Pharmacol. 57:317–327. 2006. View Article : Google Scholar
|
|
40
|
Yu J, Sun R, Zhao Z and Wang Y:
Auricularia polytricha polysaccharides induce cell cycle arrest and
apoptosis in human lung cancer A549 cells. Int J Biol Macromol.
68:67–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang F, Zhang T, Teng ZH, Zhang R, Wang
JB and Mei QB: Sensitization to gamma-irradiation-induced cell
cycle arrest and apoptosis by the histone deacetylase inhibitor
trichostatin A in non-small cell lung cancer (NSCLC) cells. Cancer
Biol Ther. 8:823–831. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lv XJ, Zhao LJ, Hao YQ, Su ZZ, Li JY, Du
YW and Zhang J: Schisandrin B inhibits the proliferation of human
lung adenocarcinoma A549 cells by inducing cycle arrest and
apoptosis. Int J Clin Exp Med. 8:6926–6936. 2015.PubMed/NCBI
|
|
43
|
Yuan L, Zhang Y, Xia J, Liu B, Zhang Q,
Liu J, Luo L, Peng Z, Song Z and Zhu R: Resveratrol induces cell
cycle arrest via a p53-independent pathway in A549 cells. Mol Med
Rep. 11:2459–2464. 2015.
|
|
44
|
Sikdar S, Mukherjee A and Khuda-Bukhsh AR:
Anti-lung cancer potential of pure esteric-glycoside
condurangogenin A against nonsmall-cell lung cancer cells in vitro
via p21/p53 mediated cell cycle modulation and DNA damage-induced
apoptosis. Pharmacogn Mag. 11(Suppl 1): S73–S85. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Singh N, Nambiar D, Kale RK and Singh RP:
Usnic acid inhibits growth and induces cell cycle arrest and
apoptosis in human lung carcinoma A549 cells. Nutr Cancer. 65(Suppl
1): 36–43. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W,
De W, Wang Z and Wang R: The long noncoding RNA HOTAIR contributes
to cisplatin resistance of human lung adenocarcinoma cells via
downregualtion of p21WAF1/CIP1 expression. PLoS One.
8:e772932013. View Article : Google Scholar
|
